Tranexamic Acid Reduces Bleeding during Off-Pump Coronary Artery Bypass Grafting in a Patient on Clopidogrel
10.4326/jjcvs.38.389
- VernacularTitle:クロピドグレル投与中の OPCAB 施行例でトラネキサム酸による出血対策が有効であった1例
- Author:
Hidehiko Iwahashi
;
Tadashi Tashiro
;
Noritsugu Morishige
;
Yoshio Hayashida
;
Nobuhisa Ito
;
Kazuma Takeuchi
;
Masaru Nishimi
;
Go Kuwahara
;
Yuta Sukehiro
- Publication Type:Journal Article
- Keywords:
DES;
OPCAB;
Clopidogrel;
Tranexamic acid;
Ascorbic acid
- From:Japanese Journal of Cardiovascular Surgery
2009;38(6):389-393
- CountryJapan
- Language:Japanese
-
Abstract:
A 72-year-old man was admitted to a local hospital with symptoms of unstable angina pectoris. He was given Clopidogrel for acute coronary syndrome. Coronary angiography showed left main trunk and three-vessel disease. He was then admitted to our hospital due to a sudden onset of unstable angina following shock during the PCI procedure. We performed emergency off-pump coronary artery bypass grafting (OPCAB). He received 10 mg/kg/h tranexamic acid during the operation. He also received 2,000 U ascorbic acid at the start of surgery and 2,000 U after undergoing anastomoses of the coronary artery. Postoperatively, only some minor bleeding was observed. Tranexamic acid and Ascorbic acid reduce bleeding, and transfusion requirements of packed red blood cells, platelets, and the total blood units in patients on Clopidogrel who undergo emergency OPCAB.
